Navigation Links
Verenium Announces First Commercial Cellulosic Ethanol Project
Date:1/15/2009

For more information on Verenium, visit http://www.verenium.com.

Forward Looking Statements

Statements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty. These include statements related to the Company's operations, capabilities, commercialization activities, target markets and cellulosic ethanol facilities, all of which are prospective. Such statements are only predictions, and actual events or results may differ materially from those projected in such forward-looking statements. Factors that could cause or contribute to the differences include, but are not limited to, risks associated with Verenium's new and uncertain technologies, risks associated with the costs, labor requirements and labor availability associated with Verenium's demonstration plant, risks associated with Verenium's ability to obtain additional capital to support its planned operations, risks associated with Verenium's dependence on patents and proprietary rights, risks associated with Verenium's protection and enforcement of its patents and proprietary rights, technological, regulatory, competitive and other risks related to development, production, and commercialization of cellulosic ethanol and other biofuels and the commercial prospects of those industries, Verenium's dependence on existing collaboration, manufacturing, and/or license agreements, and its ability to achieve milestones under existing and future collaboration agreements, the ability of Verenium and its partners to commercialize products (including by obtaining any required regulatory approvals) using Verenium's technologies and timing for launching any commercialized products, the ability of Verenium and its collaborators to market and sell any products that it or they commercialize, the development or availability of competitive products or technologies, the future
'/>"/>

SOURCE Verenium Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Verenium Regains Compliance With Nasdaq Continued Listing Requirement
2. Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
3. Verenium Corporation to Announce Third Quarter 2008 Financial Results
4. Verenium Corporation to Present at the William Blair & Company 2008 Small-Cap Growth Stock Conference
5. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
6. Verenium Appoints John F. Dee to Board of Directors
7. Verenium Reports Financial Results for the First Quarter 2008
8. Verenium Corporation to Present at Piper Jaffray Clean Technology & Renewables Conference
9. Verenium Explores Bacterial Genes Inside Termite Guts to Understand How Wood is Broken Down and Converted to Energy
10. Verenium Corporation to Present at the Pacific Growth Equities 2007 Clean Technology & Industrial Growth Conference
11. Verenium Advances Its Development Work With Cargill on a New Food-Related Product

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Ambassador to Speak at Economic Club of... (Vocus) November 25, 2009 -- Ambassador to Speak ...ppia, French Ambassador for International Investme...gency ,To view a biography of David Appia go to w...pia is available to meet with press to discuss rec...
(Date:11/25/2009)...,Nov.25/PRNewswire/--Reportlinker.comannouncesthat... ,, BrazilBioethanolMarketAnalysisandForecasts...3/Brazil-Bioethanol-Market-Analysis-and-Forecasts-...andForecaststo2013 ,, Summary ,, Thereport...ethanolmarketandtheBrazilbioethanolmarketinparticu...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ..., , ,Who: David Appia, French Ambassador for Inter...nvest in France Agency, , , , ,What: Ambassador A...cent pro-business initiatives adopted by France to...c landscape for innovation and development., , ,Wh...
(Date:11/24/2009)...IK,Iceland,November24/PRNewswire-FirstCall/--deCOD...hasreceivednoticefrom,theNasdaqStockMarketthattrad...vember30,2009andaForm25-NSEwillbefiledwiththe,Secu...scommonstock,fromlistingonNasdaq,unlessthecompanyf....Thecompanyhasfiledsuchanappeal,which,willstaythes...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...Dec. 19 /PRNewswire-FirstCall/ - Helix BioPharma C... of its previously announced,private placement, fo...BioPharma Corp., Helix BioPharma Corp. is a bioph...cancer therapy. The Company is actively developing...ent of cancer based on its,proprietary technologie...
...J., Dec. 19 Amicus Therapeutics,Inc. (Nasdaq: FO...-molecule,orally administered pharmacological chap..., announced today positive results from its recent... (migalastat hydrochloride),for Fabry disease. As ...tnership with Shire Human Genetic Therapies (HGT),...
...chnologies & Bioressources Inc. enters into an exc...onal Inc. for Australia and New ...wire-FirstCall/ - Neptune Technologies &,Bioressou... pleased to,announce that it has entered into an e...ional Inc. ("AZPA International") for Australia an...
Other Biology Technology:Helix BioPharma closes $16.9 million private placement of common shares 2Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 2Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 3Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 4Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 5Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 6Nationwide product launch of NKO(R) planned for February 2008 in Australia and New Zealand 2Nationwide product launch of NKO(R) planned for February 2008 in Australia and New Zealand 3
(Date:11/24/2009)... science is opening new doors to understanding how...e hearing of a marine mammal or if they hear it a... X-ray scanners that NASA uses to detect flaws in ... now allowing scientists to peek inside the giant ...three-dimensional replicas of a whale,s hearing an...
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wild...report revealing that the last remaining populatio...ntly due to the rising tide of poaching and habita...elp inform Russian officials of what needs to be d...s biggest cat. , The report was rel...
(Date:11/23/2009)...NATINew research presents strong evidence that the...th outdoor traffic-related pollution and indoor en...one or the other exposure alone. , Environment...ti (UC) College of Medicine have shown that childr...particles and indoor endotoxin during early life a...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2PDL BioPharma to Present at BMO Capital Markets Healthcare Conference on August 5 2009 13256 1Organic May Not Mean Healthier 53137 1Organic May Not Mean Healthier 53137 2Organic May Not Mean Healthier 53137 3In Case You Missed It 3A The Washington Posts Ruth Marcus 3A A Bipartisan Plan on Health Care 3F Try Two 53134 1In Case You Missed It 3A The Washington Posts Ruth Marcus 3A A Bipartisan Plan on Health Care 3F Try Two 53134 2
...lls the superbug MRSA is being developed under a n...ing Drug Discovery initiative is aimed at catalysi...need. , Prolysis, an R&D company based in Oxf...rug Discovery awards for its new antibacterial com...sistant infections caused by staphylococci, includ...
...how erectile dysfunction (ED) interacts with diabe...ink between the two disorders, and may lead to imp...of Central Nitric Oxide Triggers Erectile Dysfunct...liam G. Mayhan, and Kaushik P. Patel, Departments ...e R. Bidasee, Department of Pharmacology, Universi...
...may mean big things for cancer patients in the fut...the University of Kentucky published their finding...tific journal. , The researchers genetically mapp...in, and building on that effort, carried the inves... of the gene itself. This is the first time such a...
Other Biology News:New antibacterials being developed to tackle MRSA superbug 2Erectile dysfunction in diabetes is due to selective defect in the brain 2Erectile dysfunction in diabetes is due to selective defect in the brain 3Researchers first to map gene that regulates adult stem cell growth 2
Secure-Seal hybridization chambers from Sigma-Aldrich
...th • Reusable, press-to-seal gasket and cover...d disassembled for hybridizing and imaging thick o... to a 13 mm diameter. Build up to three chambers p...aporation and leaking even when submerged. RNase-f...
LC-NMR-MSn system from Bruker Daltonics
...s an aqueous solution that contains a purified bov...als in a saline solution, pH 6.5 7.5, and contain....02% bromonitrodioxane as a preservative. StabilZ...for biologically active components in solution, an...
Biology Products: